Madan G Kundu

5PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Probability theoryForensic evaluation, inference and statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2023
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.

Suzanne George, Michael C Heinrich, Neeta Somaiah

|Jul 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.

Andrew B Lassman, Stephanie L Pugh, Tony J C Wang

|Jun 16, 2021
Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover).

Shannon L Puhalla, Véronique Diéras, Banu K Arun

|Feb 24, 2021
On information fraction for Fleming-Harrington type weighted log-rank tests in a group-sequential clinical trial design.

Madan G Kundu, Jyotirmoy Sarkar

|Mar 19, 2020
Comments on "Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects" by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287-303, 2019, DOI: 10.1002/pst.1923.

Madan G Kundu

Pageof 1

Frequent Collaborators

1 joint publications

Véronique Diéras

1 joint publications

Hans Wildiers

1 joint publications

Teresa Helsten

1 joint publications

Michael Friedlander